Cigna Group (CI)
(Delayed Data from NYSE)
$334.79 USD
+1.23 (0.37%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $334.88 +0.09 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CI 334.79 +1.23(0.37%)
Will CI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CI
Can Elevance Health (ELV) Beat Q2 Earnings on Lower Expenses?
Select Medical (SEM) Expands Rehabilitation Services in Central PA
CI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Other News for CI
The Cigna Group Publishes 2023 ESG Report, Furthering Its Commitment to Advancing Better Health for All
The Cigna Group's Second Quarter 2024 Earnings Release Details
CVS, Cencora drop as Walgreens announces store closures
Cigna’s Strong Market Position and Growth Outlook Justify Buy Rating
Cigna, Humana started at overweight at Piper Sandler